EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H’28 ...
Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing ...
JavaScript is a great language. It has a simple syntax, large ecosystem and, what is most important, a great community. At the same time, we all know that JavaScript is quite a funny language with ...
At the same time, VIS-101 is also an important driver, and I apologise for now focusing on it too much. It provides a second leg to the story here, with a Phase 2b initiation expected sometime in 2H26 ...
Secure Ad Serving (HTTPS): All third-party served creatives and their components (images, stylesheets, JavaScript, tracking pixels, etc.) must be secure (HTTPS) to ensure compliance and correct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results